Abstract
A 45-year-old woman was referred from Department of Dermatology to Surgery outpatient department with pruritus since 6 months and an episode of jaundice that lasted for 15 days about 6 months ago. She was referred with a contrast-enhanced MRI finding that showed a small lesion in the lower end of common bile duct. Endoscopy-guided biopsy was performed twice at our hospital, the second revealed low grade dysplasia. Consequently, she underwent pancreaticoduodenectomy. Intraoperatively, there were both vascular and biliary anatomical variations that were missed on preoperative images. On histopathological examination, it turned out to be a mixed variety of intraductal papillary neoplasm of bile duct (IPNB). As all findings were rare in one, hence, we present this case of IPNB that presented to us with variable clinical, radiological, surgical and pathological findings.
Keywords: biliary intervention, pancreas and biliary tract, gastrointestinal surgery, general surgery
Background
Biliary tract malignancies usually arise spontaneously without any precursor lesion. However, occasionally intraductal non-invasive lesions may be identified accompanying adenocarcinoma. According to the 2010 WHO classification, intraductal papillary neoplasm of bile duct (IPNB) is one such entity.1 It includes intraductal papillary cholangiocarcinoma and similar precursor lesions as well. It usually presents in age group between 50 and 70 years and has male predominance.2 The usual complaints include features of obstructive jaundice (like biliary colic, icterus and occasionally fever).2 However, we present a case of IPNB which presented with all the surprises such as unusual history, imaging, difficulty in preoperative diagnosis, challenges during surgery and histological surprise.
Case presentation
A 45-year-old woman was referred from a different hospital (department of dermatology) to our hospital (surgery outpatients department) with generalised pruritus for the last 6 months. She presented with a contrast-enhanced MRI finding that showed a small enhancing soft tissue at the lower end of common bile duct (CBD). On further probing, she revealed the history of yellowish discolouration of eyes which lasted for a fortnight about 6 months ago. However, there was no history of weight loss, clay coloured stool and high coloured urine. On examination, she was haemodynamically stable, well nourished and ECOG 1 (performance status). There was no icterus and her abdominal examination revealed palpable, non-tender gall bladder.
Investigations
Her complete blood count and renal function tests were within normal limit. Liver function tests showed normal bilirubin level, coagulation profile and serum albumin/globulin levels. However, liver enzymes were slightly elevated: aspartate amino transferase was 109 IU/L and alanine amino transferase was 110 IU/L. Her alkaline phosphatase was markedly elevated to 1388 IU/L as was CA 19–9 which was raised to 109 U/mL. Ultrasonography of the abdomen showed dilated CBD (12 mm) and mild intrahepatic biliary radicle dilatation (IHBRD). Her contrast-enhanced CT (CECT) of the abdomen revealed ill marginated hypo enhancing 13×15 mm mass lesion involving ampullary region with abrupt cut-off at distal CBD and double duct sign (dilatation of CBD and main pancreatic duct) with IHBRD. Her contrast-enhanced MRI showed minimal central IHBRD. Axial T2-weighted image showed two hyperintense rounded structures in one section only, which was interpreted as due to tortuosity as both proximal and distal images showed a single lumen (figure 1). Arterial variant anatomy was not visualised on the available venous phase contrast-enhanced images. She underwent side viewing endoscopy and biopsy twice. The second biopsy showed a few villi form structures representing adenoma with low grade dysplasia. The case was discussed with multidisciplinary team. Owing to the presence of mass in the lower end of CBD and a preoperative biopsy suggestive of dysplasia, our preoperative clinicoradiological stage was T1N0M0. With these available findings an intraoperative frozen section was not considered, and she was planned for exploratory laparotomy and pancreaticoduodenectomy. The patient was informed about her clinicopathological findings and our plan for surgical intervention. A written and informed consent was obtained prior to the surgery (exploratory laparotomy and pancreaticoduodenectomy). MR cholangiopancreatography was not done prior to the surgery.
Figure 1.
Contrast-enhanced MRI of abdomen and pelvis. Arrow is showing two hyper intense rounded structures in T2-weighted image that was interpreted as tortuosity as both proximal and distal images showed a single lumen.
Differential diagnosis
Differential diagnosis for lower CBD lesions with diverse range of presentations are enumerated in table 1
Table 1.
Differential diagnosis for lower CBD lesions with diverse range of presentation
| Cholangiocarcinoma | Tuberculosis | IGG4-related disease | |
| Demographics | Old (over 50 years), male predominant. Higher prevalence in Asia with chronic parasitic infestation |
Common in Indian subcontinent and tropical countries | Older age (median age 50 years), male predominant |
| Clinical features | Painless, persistent progressive obstructive jaundice with a palpable gall bladder Loss of weight and loss appetite present |
Painless progressive obstructive jaundice of chronic duration, Intermittent fever. Loss of weight and loss appetite present |
Obstructive jaundice |
| Possible history (may be present) | Recurrent cholangitis. | Past surgical history of gastrojejeunostomy and truncal vegotomy Lymphnodes palpable in neck or axilla. |
Diverse range of clinical presentation. Obstructive jaundice (most common) and gastrointestinal bleeding (rare). Single or multiple organs involved with diffuse or multiple swellings, nodules, and or hypertrophic lesions. |
| Blood or body fluid test | Non diagnostic | Suggestive: raised ESR Lymphocytosis. Peritoneal or pleural fluid: raised ADA | Suggestive: Serum IGG4 level elevated in 70% cases. |
| Imaging: lower CBD lesions | Intraductal tumour (papillary or polypoidal mass), proximal ductal dilatation, multifocal and relatively hypoattenuating. Bile duct wall thickening and enhancement. | Stricture and soft tissue lesion (pseudotumour) in lower CBD, with proximal ductal dilatation | Stricture and stenosis of bile duct |
| Preoperative biopsy (side view endoscopy and biopsy) | Diagnostic of adenocarcinoma | SVE with brush cytology, PCR for bile sample aspirated from bile duct, FNAC of lymphnode, CBNAAT positive of tissue biopsy | Difficulty in achieving preoperative diagnosis. |
| Histopathological examination | Moderate to well-differentiation adenocarcinoma, with glandular and tubular structure, | Granulomatous lesions in lower CBD lesion, granulomatous lymphadenitis, caseation necrosis, epitheloid granuloma formation. langhans giant cells | Lymphoplasmacytic infilteration positive for IGG4 immunostaining and fibrosis, and phlebitis. IgG4 positive plasma cells exceeding 10/HPF |
| Diagnosis | Clinicopathological diagnosis | Clinicopathological diagnosis + Response to antitubercular treatment (systemic symptoms improvement) |
Histology, imaging, serology, other organ involvement and response to therapy |
ADA, Adenosine deaminase; CBD, common bile duct; CBNAAT, Cartridge-based nucleic acid amplification test; ESR, Erythrocyte sedimentation ratio; FNAC, Fine-needle aspiration cytology; HPF, High-power field; PCR, Polymerase chain reaction; SVE, Side view endoscopy.
Treatment
The patient was planned for exploratory laparotomy with a possibility of pancreaticoduodenectomy. Intraoperatively, hepatic flexure mobilisation and kocherisation was done followed by isolation of infra pancreatic superior mesenteric vein. This was followed by portal dissection which included identification of the right hepatic artery lying lateral and posterior to portal vein. It was found to be originating from superior mesenteric artery (figure 2) and left hepatic artery arising from coeliac trunk. Gastroduodenal artery was identified and ligated. Pyloroduodenal junction was transacted using staple, and pancreas was transacted at the neck anterior to portal vein using harmonic shear scissors after creating a tunnel between the neck and superior mesenteric vein. Jejunum was transacted about 15 cm distal to the duodenojejunal junction and specimen was delivered into the lesser sac. CBD was traced superiorly and two different ducts visualised, one being a sectoral duct which joined at the junction of common hepatic duct and cystic duct. Both sectoral duct and common hepatic duct were transacted separately. Specimen was delivered after dissection of uncinate process from the portal vein (figure 3). Subsequently, pancreaticojejunostomy (Dunkin’s technique), two separate hepaticojejunostomies (figure 4) and gastrojejunostomy were done along with feeding jejunostomy. Abdomen was closed in layers after placing drains.
Figure 2.

Ct angiography image showing replaced right hepatic artery (short arrow) arising from superior mesenteric artery (long arrow).
Figure 3.

Resected specimen showing two ducts viz. Common hepatic duct and right posterior sectoral duct. Arrow pointing to large size open duct is the cut end of common hepatic duct and the arrow showing small size open duct is the cut end of sectoral duct.
Figure 4.

Postoperative MRCP image showing two separate anastomoses of right posterior sectoral duct (long arrow) and common hepatic duct (curved arrow) into the jejunum. MRCP, magnetic resonance cholangiopancreatography.
Outcome and follow-up
Postoperative recovery was uneventful. Feeds were started through feeding jejunostomy tube on postoperative day (POD) 2. Drain to blood amylase ratio was 32:29 on POD 3. On POD 8, pancreaticojejunostomy site drain was removed; subsequently, she was discharged with the drain placed at the site of hepaticojejunostomies as it had high serous fluid in the drain. During the follow-up visit on POD 15, the drain placed at the site of hepaticojejunostomies was removed. Histopathological evaluation revealed IPNB with high-grade dysplasia. There was mixed foveolar and intestinal differentiation (figure 5). It had already spread to the overlying duodenal mucosa. Contrast-enhanced MRI study was performed at 6 months after surgery did not show papillary neoplasms in liver and pancreas. The patient is still under the follow-up.
Figure 5.
Immunohistochemical analysis of markers for IPNB histological subtypes—positive for MUC5A (gastric) and CK-19 (intestinal). IPNB, intraductal papillary neoplasm of bile duct.
Discussion
IPNB is an uncommon condition and has a wide spectrum of clinical presentation and radiological findings.3 Preoperatively, it is usually a diagnostic challenge in view of the variety of presentations. Clinically, it may present with abdominal colic, symptoms suggestive of obstructive jaundice or cholangitis. However, isolated presentation of generalised pruritus as the only presentation of IPNB has not been mentioned in the English literature. Our case had history of prolonged pruritus over a period of 6 months and jaundice that lasted for fortnight in the beginning. Similarly, radiological findings may vary from ductal dilatation which may be mild to severe, diffuse or focal, with or without any intraductal mass, or small lesions such as cast or focal stricture; nonetheless, the most common radiological presentation mentioned in the literature was diffuse duct dilatation with intraductal mass in around half of the cases.4 5 Radiological imaging is important to delineate the biliary anatomy. A study observed normal biliary anatomy in only 57.6% of population.6 We found a rare variant of biliary anatomy in our patient-A5 (1.6%) in classification given by Huang et al.7 Also, we noted variation in origin of right hepatic artery intraoperatively. It was found to be arising from superior mesenteric artery (type 3).8
An elevated level of alanine amino transferase is the only test found to differentiate it from conventional cholangiocarcinoma.9 Yeh et al analysed CA19-9 to be elevated at a greater frequency in patients with malignant IPNB (61%) as compared with benign (35%).10 Similarly, carcinoembryonic antigen (CEA) was found to be raised in around 25% of patients with malignant IPNB.10 In our case, we found elevation of CA 19-9 while CEA was not tested and it turned out to be a low grade dysplasia without invasion.
A proper preoperative evaluation would include ultrasonography to look for bile duct dilatation and differentiate from choledocholithiasis. Endoscopic ultrasonography is a good modality to evaluate the depth of invasion and lymph node involvement.11 12 CECT and contrast-enhanced MRI may also help to detect tumours larger than 1 cm and proximal or distal bile duct dilatation. Contrast enhancement is less likely to be persistent and these lesions usually present with washout of enhancement. Magnetic resonance cholangiopancreatography may further elucidate the extent of tumour, its multifocality and narrowing of the bile ducts.13 14 However, endoscopic or transhepatic cholangiography or per oral cholangioscopy remain superior as they are able to demonstrate mucin overproduction and identify additional lesions.15 16 Cholangioscopy is recommended to evaluate the extent of lesion and tailor the resection which may be done preoperatively or intraoperatively.16
The main modality of treatment for those without distant metastasis remains surgical resection. Intraoperative frozen sections can further help in tailoring the resection. If only intrahepatic ducts are involved, hepatectomy may suffice. Extrahepatic and extrapancreatic duct involvement may need complete resection from formation of CBD and intrapancreatic portion. Positive proximal or distal frozen section may require addition of partial liver or pancreatic resection.17 However, some even advocate a complete removal of biliary tree by liver transplantation and pancreaticoduodenectomy.18 19 In our case, we did complete removal of extra hepatic biliary tree and pancreaticoduodenectomy.
Kim et al reported difference in clinical features and prognosis in different histological types.4 Histopathology report suggested a mixed pancreaticobiliary and foveolar pattern of growth in our case. While intestinal variant is the most common, oncocytic histological subtype is uncommon in Asian population.4 Pancreaticobiliary type being the most aggressive while gastric the least. However, mixed subtype is not mentioned in the English literature. Survival and prognosis of these patients depends on histological subtype, differentiation, extent of resection (R0 vs R1), presence and depth of invasive component and lymphovascular invasion. In view of pancreaticobiliary subtype with high-grade dysplasia this case warrants a close follow-up. In our case, a contrast-enhanced MRI study was done at 6 months follow-up period. The scan did not show any lesion (papillary neoplasms) in the liver and pancreas. Furthermore, this patient would undergo a close follow-up with clinical examination and ultrasonography 6 monthly, and MRI studies involving abdomen with MR cholangiopancreatography annually.
Learning points.
Intraductal papillary neoplasm of bile duct (IPNB) is very uncommon condition and has a wide spectrum of clinical, radiological and pathological presentations.
IPNB with its variable findings poses a diagnostic challenge and is confirmed by histopathological evaluation.
Pancreaticobiliary anomalies are a rule and not an exception; surgeon should have knowledge and skills to prevent inadvertent injury to vital structures.
Regular follow-up of the case is required as IPNBs are known to present as second primary in remaining ducts in liver and pancreas.
Prognosis of IPNB depends on histological subtype, resected margin, depth of invasion and lymph node status.
Acknowledgments
We thank Surabhi Vyas, Additional Professor, Department of Radiodiagnosis for providing all the details with respect to preoperative and postoperative images.
Footnotes
Contributors: MMP conceived the design. MMP was the first operating surgeon; Patient was evaluated, worked up and discussed by AC. PS was involved in radiological discussion and arriving at diagnosis.KJ was involved in histopathological examination of the specimen. Patient was operated by MMP. MMP and AC collected the operating steps. Demography of the patient, clinical details and video editing was done by AC, PS and KJ and further it was analysed by MMP. Manuscript was prepared by MMP, AC, PS and KJ. Editing of image was performed by AC and MMP. Case report was written, critically analysed, revised and uploaded by MMP. Responses to the reviewers was written by MMP after consulting radiology faculty. Final approval of the case report is provided by MMP, AC, PS and KJ. Overall responsibility and corresponding author is MMP.
Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests: None declared.
Patient consent for publication: Obtained.
Provenance and peer review: Not commissioned; externally peer reviewed.
References
- 1.Bosman FT. International Agency for Research on Cancer : Who classification of tumours of the digestive system. 4th edn Lyon: International Agency for Research on Cancer, 2010: 417. [Google Scholar]
- 2.Rocha FG, Lee H, Katabi N, et al. Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? Hepatology 2012;56:1352–60. 10.1002/hep.25786 [DOI] [PubMed] [Google Scholar]
- 3.Ohtsuka M, Kimura F, Shimizu H, et al. Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion. Am J Surg Pathol 2011;35:512–21. 10.1097/PAS.0b013e3182103f36 [DOI] [PubMed] [Google Scholar]
- 4.Kim KM, Lee JK, Shin JU, et al. Clinicopathologic features of intraductal papillary neoplasm of the bile duct according to histologic subtype. Am J Gastroenterol 2012;107:118–25. 10.1038/ajg.2011.316 [DOI] [PubMed] [Google Scholar]
- 5.Lim JH, Jang K-T. Mucin-Producing bile duct tumors: radiological-pathological correlation and diagnostic strategy. J Hepatobiliary Pancreat Sci 2010;17:223–9. 10.1007/s00534-009-0154-y [DOI] [PubMed] [Google Scholar]
- 6.Puente SG, Bannura GC. Radiological anatomy of the biliary tract: variations and congenital abnormalities. World J Surg 1983;7:271–6. 10.1007/BF01656159 [DOI] [PubMed] [Google Scholar]
- 7.Huang TL, Cheng YF, Chen CL, et al. Variants of the bile ducts: clinical application in the potential donor of living-related hepatic transplantation. Transplant Proc 1996;28:1669–70. [PubMed] [Google Scholar]
- 8.Hiatt JR, Gabbay J, Busuttil RW. Surgical anatomy of the hepatic arteries in 1000 cases. Ann Surg 1994;220:50–2. 10.1097/00000658-199407000-00008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Yeh C-N, Jan Y-Y, Yeh T-S, et al. Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma. Ann Surg Oncol 2004;11:606–11. 10.1245/ASO.2004.04.028 [DOI] [PubMed] [Google Scholar]
- 10.Yeh T-S, Tseng J-H, Chen T-C, et al. Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions. Hepatology 2005;42:657–64. 10.1002/hep.20837 [DOI] [PubMed] [Google Scholar]
- 11.Takanami K, Yamada T, Tsuda M, et al. Intraductal papillary mucininous neoplasm of the bile ducts: multimodality assessment with pathologic correlation. Abdom Imaging 2011;36:447–56. 10.1007/s00261-010-9649-x [DOI] [PubMed] [Google Scholar]
- 12.Tsuyuguchi T, Sakai Y, Sugiyama H, et al. Endoscopic diagnosis of intraductal papillary mucinous neoplasm of the bile duct. J Hepatobiliary Pancreat Sci 2010;17:230–5. 10.1007/s00534-009-0153-z [DOI] [PubMed] [Google Scholar]
- 13.Yoon HJ, Kim YK, Jang K-T, et al. Intraductal papillary neoplasm of the bile ducts: description of MRI and added value of diffusion-weighted MRI. Abdom Imaging 2013;38:1082–90. 10.1007/s00261-013-9989-4 [DOI] [PubMed] [Google Scholar]
- 14.Takanami K, Hiraide T, Kaneta T, et al. Fdg PET/CT findings in malignant intraductal papillary mucinous neoplasm of the bile ducts. Clin Nucl Med 2010;35:83–5. 10.1097/RLU.0b013e3181c7bff0 [DOI] [PubMed] [Google Scholar]
- 15.Yeh T-S, Tseng J-H, Chiu C-T, et al. Cholangiographic spectrum of intraductal papillary mucinous neoplasm of the bile ducts. Ann Surg 2006;244:248–53. 10.1097/01.sla.0000217636.40050.54 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Lee SS, Kim M-H, Lee SK, et al. Clinicopathologic review of 58 patients with biliary papillomatosis. Cancer 2004;100:783–93. 10.1002/cncr.20031 [DOI] [PubMed] [Google Scholar]
- 17.Jarnagin WR, Bowne W, Klimstra DS, et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 2005;241:703–14. 10.1097/01.sla.0000160817.94472.fd [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Imvrios G, Papanikolaou V, Lalountas M, et al. Papillomatosis of intra- and extrahepatic biliary tree: successful treatment with liver transplantation. Liver Transpl 2007;13:1045–8. 10.1002/lt.21207 [DOI] [PubMed] [Google Scholar]
- 19.Vibert E, Dokmak S, Belghiti J. Surgical strategy of biliary papillomatosis in Western countries. J Hepatobiliary Pancreat Sci 2010;17:241–5. 10.1007/s00534-009-0151-1 [DOI] [PubMed] [Google Scholar]


